Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations [1] (multiple letters)

Roberto Imberti, Andrew I R Maas, Ewout W. Steyerberg

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)241-242
Number of pages2
JournalNeurosurgery
Volume53
Issue number1
Publication statusPublished - Jul 1 2003

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this